About
Carl Salzman, MD, affiliated with Harvard Medical School in Boston, Massachusetts, has contributed extensively to the fields of psychiatry and psychopharmacology since 1999. His publications address clinical management and treatment considerations for major depressive disorder, schizophrenia and schizoaffective disorders, anxiety, dementia, and suicidality, with a focus on long-term benzodiazepine use and geriatric psychopharmacology. Salzman has also explored clinical trial methodologies and consensus statements related to psychiatric conditions in elderly populations.
